Gene protecting against age-related macular degeneration

被引:0
|
作者
Amouyel, P [1 ]
机构
[1] Inst Pasteur, INSERM U508, F-59019 Lille, France
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Age-related macular degeneration (ARMD) is the most common cause of blindness in the elderly in Europe and in the United States ARMD is a multifactorial disease process corresponding to a thinning or scarring of the center of the retina, the macula. Some risk factors that have been associated with ARMD include less skin pigmentation, cigarette smoking, systemic hypertension, low intake of antioxidants and family history The main clinical retinal markers of ARMD are drusen, which are composed of protein and lipid deposits within the Bruch's membrane. The lipid composition of drusen and the possible influence of genetic susceptibility risk factors prompted us to consider the gene coding for a protein involved in lipid transport, apolipoprotein E (APOE), as an interesting candidate risk factor for ARMD occurrence. In a case control study, we compared patients with exudative ARMD to controls of similar age and gender. We observed a lower frequency of the APOE epsilon 4 allele in patients with exudative ARMD. For non APOE epsilon 4 allele bearers, the relative risk of developing exudative ARMD was almost five-fold higher than for APOE epsilon 4 allele bearers. This intriguing protective effect of the APOE epsilon 4 allele, which is commonly known to be deleterious for the vascular system and cognitive performance, opens up several questions related to disease origin, gene evolution and genetic testing.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 50 条
  • [1] Gene therapy for age-related macular degeneration
    MacLaren, Robert E.
    LANCET, 2015, 386 (10011): : 2369 - 2370
  • [2] Gene therapy for age-related macular degeneration
    Moore, Nicholas A.
    Bracha, Peter
    Hussain, Rehan M.
    Morral, Nuria
    Ciulla, Thomas A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (10) : 1235 - 1244
  • [3] Gene Therapy for Age-Related Macular Degeneration
    Constable, Ian Jeffery
    Blumenkranz, Mark Scott
    Schwartz, Steven D.
    Barone, Sam
    Lai, Chooi-May
    Rakoczy, Elizabeth Piroska
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2016, 5 (04): : 300 - 303
  • [5] Nutritional Interventions against Age-Related Macular Degeneration
    Bernstein, P. S.
    II INTERNATIONAL SYMPOSIUM ON HUMAN HEALTH EFFECTS OF FRUITS AND VEGETABLES: FAVHEALTH 2007, 2009, 841 : 103 - 111
  • [6] Protecting the Mitochondria as a Therapeutic Strategy for dry Age-Related Macular Degeneration
    Ferrington, Deborah A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [7] Gene Therapies for Neovascular Age-Related Macular Degeneration
    Pechan, Peter
    Wadsworth, Samuel
    Scaria, Abraham
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2015, 5 (07):
  • [8] Interleukin gene polymorphisms in age-related macular degeneration
    Tsai, Yi-Yu
    Lin, Jane-Ming
    Wan, Lei
    Lin, Hui-Ju
    Tsai, Yushin
    Lee, Cheng-Chun
    Tsai, Chang-Hai
    Tsai, Fuu-Jen
    Tseng, Sung-Huei
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (02) : 693 - 698
  • [9] Gene silencing in wet age-related macular degeneration
    Arjamaa, Olli
    LANCET, 2006, 368 (9536): : 630 - 631
  • [10] Nonviral gene therapy for age-related macular degeneration
    Thumann, Gabriele
    EXPERT REVIEW OF OPHTHALMOLOGY, 2011, 6 (01) : 81 - 93